{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:10:10Z","timestamp":1724796610565},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>Pregnant patients are at increased risk of severe illness, in-hospital mortality, and preterm birth in the setting of coronavirus disease 2019 (COVID-19); however, they often are excluded from clinical trials that analyze improved therapeutics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Thus, there are relatively few available data that examine the safety of monoclonal antibodies (mAbs) in pregnant patients with COVID-19, which we aimed to explore in this systematic review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>We searched PubMed, Cochrane, EMBASE, and Google Scholar on September 30, 2022. Included studies encompassed English-language case reports with at least five participants, cross-sectional studies, case\u2013control studies, cohort studies, retrospective or prospective chart reviews, and randomized controlled trials that enrolled pregnant women who received SARS-CoV-2\u2013targeted mAbs. Studies were screened for eligibility using Covidence according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines and were subsequently evaluated for risk of bias with the JBI critical appraisal checklist.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n            <jats:p>Initial search yielded 616 studies; 13 publications were ultimately eligible. Pregnant patients were treated with SARS-CoV-2\u2013neutralizing mAbs casirivimab-imdevimab, bamlanivimab, or bamlanivimab-etesevimab. A total of 365 patients were treated with casirivimab-imdevimab, 13 were treated with bamlanivimab, and 11 were treated with bamlanivimab-etesevimab. There were no cases of maternal mortality. Eighteen of the 389 patients had adverse effects related to mAb administration\u2014all resolved. Of the patients treated with casirivimab-imdevimab, there were 35 preterm deliveries, two fetal deaths, one neonatal death due to sepsis, five cases of preterm prelabor rupture of membranes (PROM), one case of PROM, and 24 neonatal intensive care unit (NICU) admissions. Of the patients treated with bamlanivimab, there was one case of preterm PROM and one preterm delivery. There were no NICU admissions in the bamlanivimab or bamlanivimab-etesevimab cohorts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Preliminary data suggest that neutralizing mAb treatment for COVID-19 in pregnant patients is safe. However, treatment-associated events support the importance of clinical trials to determine the statistical significance of maternal and fetal outcomes in pregnant patients treated with SARS-CoV-2\u2013targeted mAbs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/og9.0000000000000007","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T21:00:26Z","timestamp":1716325226000},"page":"007","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Safety of Monoclonal Antibodies as Treatment for Coronavirus Disease 2019 (COVID-19) During Pregnancy"],"prefix":"10.1097","volume":"1","author":[{"given":"Mona","family":"Bugaighis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Milosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cervia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,6]]},"reference":[{"key":"R1-20240827","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/GRF.0000000000000674","article-title":"The Epidemiology of COVID-19 in pregnancy","volume":"65","author":"Overton","year":"2022","journal-title":"Clin Obstet Gynecol"},{"key":"R2-20240827","doi-asserted-by":"crossref","first-page":"m3320","DOI":"10.1136\/bmj.m3320","article-title":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis","volume":"370","author":"Allotey","year":"2020","journal-title":"BMJ"},{"key":"R3-20240827","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamapediatrics.2021.1050","article-title":"Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort Study","volume":"175","author":"Villar","year":"2021","journal-title":"JAMA Pediatr"},{"key":"R4-20240827","doi-asserted-by":"crossref","first-page":"e2120456","DOI":"10.1001\/jamanetworkopen.2021.20456","article-title":"Characteristics and outcomes of women with COVID-19 giving birth at US Academic Centers during the COVID-19 Pandemic","volume":"4","author":"Chinn","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R5-20240827","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/AOG.0000000000004339","article-title":"Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19)","volume":"137","author":"Metz","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R6-20240827","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1093\/eurheartj\/ehab103","article-title":"Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity","volume":"42","author":"Van Spall","year":"2021","journal-title":"Eur Heart J"},{"key":"R7-20240827","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/AOG.0000000000003924","article-title":"Protection by exclusion: another missed opportunity to include pregnant women in research during the coronavirus disease 2019 (COVID-19) pandemic","volume":"136","author":"Costantine","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R8-20240827","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/S2214-109X(20)30484-8","article-title":"Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action","volume":"9","author":"Taylor","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R9-20240827","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1056\/NEJMoa2108163","article-title":"REGEN-COV antibody combination and outcomes in outpatients with covid-19","volume":"385","author":"Weinreich","year":"2021","journal-title":"N Engl J Med"},{"key":"R11-20240827","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred reporting Items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"R13-20240827","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s15010-022-01777-z","article-title":"Treatment with anti-SARS-CoV-2 monoclonal antibodies in pregnant and postpartum women: first experiences in Florence, Italy","volume":"50","author":"Manciulli","year":"2022","journal-title":"Infection"},{"key":"R14-20240827","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s15010-022-01829-4","article-title":"Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy","volume":"51","author":"Folkman","year":"2023","journal-title":"Infection"},{"key":"R15-20240827","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajog.2022.01.018","article-title":"A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy","volume":"226","author":"Chang","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20240827","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/AOG.0000000000004700","article-title":"Anti-spike monoclonal antibody therapy in pregnant women with mild-to-moderate coronavirus disease 2019 (COVID-19)","volume":"139","author":"Thilagar","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R17-20240827","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/jog.15338","article-title":"Evaluation of the tolerability of monoclonal antibody therapy for pregnant patients with COVID-19","volume":"48","author":"Magawa","year":"2022","journal-title":"J Obstet Gynaecol Res"},{"key":"R18-20240827","first-page":"113","article-title":"Monoclonal SARS-CoV-2 antibodies in pregnancy\u2014a case series","volume":"119","author":"Z\u00f6llkau","year":"2022","journal-title":"Deutsches \u00c4rzteblatt Int"},{"key":"R19-20240827","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/AOG.0000000000004826","article-title":"Outpatient use of monoclonal antibodies in pregnant individuals with mild or moderate coronavirus disease 2019 (COVID-19)","volume":"140","author":"Eid","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R20-20240827","doi-asserted-by":"crossref","first-page":"100673","DOI":"10.1016\/j.ajogmf.2022.100673","article-title":"Outcomes of pregnant patients treated with REGEN-COV during the COVID-19 pandemic","volume":"4","author":"Levey","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R21-20240827","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1134\/S1019331622040177","article-title":"Coronavirus infection COVID-19 and pregnancy","volume":"92","author":"Kurtser","year":"2022","journal-title":"Herald Russ Acad Sci"},{"key":"R22-20240827","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/AOG.0000000000004689","article-title":"Neutralizing monoclonal antibodies for coronavirus disease 2019 (COVID-19) in pregnancy: a case series","volume":"139","author":"Richley","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R23-20240827","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajog.2022.09.017","article-title":"Effectiveness of REGEN-COV combination monoclonal antibody infusion to reduce the risk of COVID-19 hospitalization in pregnancy: a retrospective cohort study","volume":"228","author":"Williams","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R28-20240827","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/AOG.0000000000004012","article-title":"Prone positioning for pregnant women with hypoxemia due to coronavirus disease 2019 (COVID-19)","volume":"136","author":"Tolcher","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R29-20240827","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.3390\/vaccines10122182","article-title":"Prone positioning: a safe and effective procedure in pregnant women presenting with severe acute respiratory distress syndrome","volume":"10","author":"Osmundo","year":"2022","journal-title":"Vaccines"},{"key":"R30-20240827","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(22)00163-5","article-title":"Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomized, controlled, open-label, platform trial","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"R32-20240827","doi-asserted-by":"crossref","first-page":"100049","DOI":"10.1016\/j.xagr.2021.100049","article-title":"Systematic review and meta-analysis of COVID-19 maternal and neonatal clinical features and pregnancy outcomes up to June 3, 2021","volume":"2","author":"Marchand","year":"2022","journal-title":"AJOG Glob Rep"},{"key":"R34-20240827","doi-asserted-by":"crossref","first-page":"2162867","DOI":"10.1080\/01443615.2022.2162867","article-title":"Evaluation of pregnancy outcomes in mothers with COVID-19 infection: a systematic review and meta-analysis","volume":"43","author":"Simbar","year":"2023","journal-title":"J Obstet Gynaecol J Inst Obstet Gynaecol"},{"key":"R36-20240827","doi-asserted-by":"crossref","first-page":"e000592","DOI":"10.1136\/bmjpo-2019-000592","article-title":"Incidence of newborn resuscitative interventions at birth and short-term outcomes: a regional population-based study","volume":"3","author":"Bjorland","year":"2019","journal-title":"BMJ Paediatrics Open"},{"issue":"10","key":"R37-20240827","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S2352-4642(20)30235-2","article-title":"Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study","volume":"4","author":"Salvatore","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"6","key":"R38-20240827","doi-asserted-by":"crossref","first-page":"100715","DOI":"10.1016\/j.ajogmf.2022.100715","article-title":"Characteristics and treatment of hospitalized pregnant women with COVID-19","volume":"4","author":"Sekkarie","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R39-20240827","article-title":"Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019","author":"Riccardo","year":"2022","journal-title":"Am J Perinatol"}],"container-title":["O&amp;G Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/og9.0000000000000007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T21:03:13Z","timestamp":1724792593000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/og9.0000000000000007"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/og9.0000000000000007","relation":{},"ISSN":["2994-9726"],"issn-type":[{"type":"electronic","value":"2994-9726"}],"subject":[],"published":{"date-parts":[[2024,5,21]]}}}